Kestra Medical Technologies KMTS
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 19th percentile, 5-year average -9.6x
Near the top of its 5-year range · 80th percentile, 5-year average 4.0x
#4779 of 5330 stocks by PB (1 = cheapest)
Around its usual level · 43rd percentile, 5-year average 17.6x
#4670 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 7.67 | – | 4.03 | 80% (pricier than usual) | #4779 of 5330 (1 = cheapest) |
| PE | -11.32 | -12.69 | -9.65 | 19% (cheaper than usual) | – |
| PS | 15.98 | 11.16 | 17.61 | 43% (cheaper than usual) | #4670 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on KMTS.
Sign in to join the discussion.